Nano-X Imaging (NASDAQ:NNOX) Given “Overweight” Rating at Cantor Fitzgerald

Nano-X Imaging (NASDAQ:NNOX)‘s stock had its “overweight” rating reissued by Cantor Fitzgerald in a note issued to investors on Monday,Benzinga reports. They currently have a $5.00 price objective on the stock. Cantor Fitzgerald’s price objective points to a potential upside of 401.15% from the stock’s current price.

A number of other brokerages have also issued reports on NNOX. Alliance Global Partners lowered Nano-X Imaging from a “buy” rating to a “neutral” rating and lowered their price target for the company from $5.00 to $3.00 in a report on Tuesday, July 7th. Weiss Ratings reissued a “sell (e+)” rating on shares of Nano-X Imaging in a research report on Wednesday, July 8th. D. Boral Capital reiterated a “buy” rating and set a $5.00 price objective on shares of Nano-X Imaging in a research note on Monday, April 20th. Finally, Zacks Research raised Nano-X Imaging from a “strong sell” rating to a “hold” rating in a research report on Monday, June 22nd. One investment analyst has rated the stock with a Strong Buy rating, two have issued a Buy rating, two have assigned a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, Nano-X Imaging presently has an average rating of “Moderate Buy” and a consensus price target of $4.33.

Nano-X Imaging Price Performance

Shares of NASDAQ NNOX opened at $1.00 on Monday. Nano-X Imaging has a 1 year low of $0.73 and a 1 year high of $4.71. The firm has a 50-day simple moving average of $1.23 and a two-hundred day simple moving average of $1.89. The company has a market cap of $69.90 million, a P/E ratio of -0.63 and a beta of 1.27.

Nano-X Imaging (NASDAQ:NNOX) last issued its quarterly earnings results on Thursday, June 25th. The company reported ($0.16) earnings per share (EPS) for the quarter. Nano-X Imaging had a negative return on equity of 70.96% and a negative net margin of 716.44%.The business had revenue of $4.31 million for the quarter. As a group, equities research analysts expect that Nano-X Imaging will post -0.6 EPS for the current year.

Insider Activity at Nano-X Imaging

In other Nano-X Imaging news, CEO Erez Meltzer bought 36,000 shares of Nano-X Imaging stock in a transaction dated Monday, July 27th. The stock was acquired at an average cost of $0.93 per share, for a total transaction of $33,480.00. Following the completion of the transaction, the chief executive officer directly owned 36,000 shares of the company’s stock, valued at approximately $33,480. This represents a ∞ increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, Director Dan S. Suesskind acquired 50,000 shares of the company’s stock in a transaction that occurred on Monday, July 27th. The shares were acquired at an average cost of $0.93 per share, with a total value of $46,500.00. Following the purchase, the director owned 50,000 shares in the company, valued at $46,500. This represents a ∞ increase in their position. The disclosure for this purchase is available in the SEC filing. Insiders have purchased 95,443 shares of company stock valued at $89,706 over the last quarter.

Institutional Trading of Nano-X Imaging

Large investors have recently added to or reduced their stakes in the stock. Kestra Advisory Services LLC purchased a new position in shares of Nano-X Imaging during the 1st quarter worth $26,000. Independent Financial Group LLC acquired a new stake in Nano-X Imaging during the first quarter worth about $26,000. Interchange Capital Partners LLC acquired a new stake in Nano-X Imaging during the fourth quarter worth about $28,000. Aristides Capital LLC acquired a new position in Nano-X Imaging in the 4th quarter valued at about $30,000. Finally, Hsbc Holdings PLC purchased a new stake in shares of Nano-X Imaging in the 1st quarter valued at approximately $35,000. 21.49% of the stock is currently owned by hedge funds and other institutional investors.

Nano-X Imaging Company Profile

Nano-X Imaging Ltd. is a medical technology company developing and commercializing a digital X-ray imaging platform designed to lower the cost and increase the accessibility of diagnostic imaging. Its flagship product, the Nanox.ARC, leverages a proprietary micro-electromechanical system (MEMS) based digital X-ray source and advanced image processing software to provide 2D and 3D imaging capabilities on a compact footprint. The system aims to streamline radiology workflows and facilitate point-of-care diagnostics in hospitals, clinics and outpatient settings.

The Nanox.ARC platform integrates a novel cold cathode X-ray source, which enables multiple emission points without the need for rotating anode tubes.